Advertisement

Topics

Meningococcal Conjugates Vaccine - Biotech, Pharma and Life Science Channel

17:37 EST 27th February 2017 | BioPortfolio

PubMed Articles [1690 Associated PubMed Articles listed on BioPortfolio]

Two approaches to the use of benzoc1,2oxaboroles as active fragments for synthetic transformation of clarithromycin().

Clarithromycin (active against Gram positive infections) and 1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborole derivatives (effective for Gram negative microbes) are the ligands of bacterial RNA. The antimi...

Invasive Haemophilus influenzae disease in the vaccine era in Rio de Janeiro, Brazil.

Haemophilus influenzae (Hi) serotype b (Hib) conjugate vaccine was incorporated into the infant immunisation schedule in Brazil in 1999, where Hib was one of the major etiologic sources of community-a...

Serology in Finfish for Diagnosis, Surveillance, and Research: A Systematic Review.

Historically, serological tests for finfish diseases have been underused when compared with their use in terrestrial animal health. For years the nonspecific immune response in fish was judged to make...

Vaccine Candidates against Nontypeable Haemophilus influenzae: a Review

Nonencapsulated, nontypeable Hemophilus influenzae (NTHi) remains an important cause of acute otitis and respiratory diseases in children and adults. NTHi bacteria are one of the major causes of respi...

Presence of PSA antibodies in seminal plasma of infertile men.

Immunoinfertility due to antisperm antibodies and semen hyperviscosity are among major causes of male infertility. Although the modulation of prostate-specific antigen (PSA) has been investigated in p...

DNA Vaccination Partially Protects Muskellunge against Viral Hemorrhagic Septicemia Virus (VHSV-IVb).

A DNA vaccine containing the glycoprotein (G) gene of the North American viral hemorrhagic septicemia virus (VHSV) genotype IVb was developed to evaluate the immune response of fish following vaccinat...

NewsCAP: A new vaccine against Ebola may be effective and safe to use in an outbreak.

Kinome Profiling Identifies Druggable Targets For Novel HCMV Antivirals.

Human cytomegalovirus (HCMV) is a significant cause of disease in immunecompromised adults and immune naive newborns. No vaccine exists to prevent HCMV infection, and current antiviral therapies have ...

Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A.

Hepatitis C virus (HCV) is a major cause of end-stage liver diseases. With 3-4 million new HCV infections yearly, a vaccine is urgently needed. A better understanding of virus escape from neutralizing...

Analysis of the T Cell Response to Zika Virus and Identification of a Novel CD8+ T Cell Epitope in Immunocompetent Mice.

Zika virus (ZIKV) is an emerging arbovirus of the Flaviviridae family. Although ZIKV infection is typically mild and self-limiting in healthy adults, infection has been associated with neurological sy...

News Articles [2300 Associated News Articles listed on BioPortfolio]

Affinivax Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 25012017] Prices from USD $250

SummaryAffinivax Inc Affinivax is a biotechnology company that focuses on the development of vaccines for infectious diseases. The company uses Multiple Antigen Presenting System MAPS technology to en...

Experimental Malaria Vaccine Offers Durable Protection Against Many Strains

NewsMalaria is transmitted to humans through the bite of infected mosquitoes, which inject immature malaria parasites called sporozoites into a person's bloodstream.

Orange County Dentist, Dr. A. Rassouli, Comments on the New Vaccine for Periodontitis

Dr. Rassouli comments on a new vaccine that can help prevent gum disease. Orange County, CA (PRWEB) February 27, 2017 Orange County dentist, Dr. A. Rassouli, comments on the new vaccine for periodont...

Merck & Co's New Shingles Vaccine Clears First Phase III Hurdle

Merck & Co has positive data from the first of two Phase III trials of its new varicella zoster virus...   

Fed Up Of Poorly Run Academic Spin-Outs? Try This Instead

Three big pharma and three major UK universities are working together to "find, fund and run academic drug discovery projects...   

Novel DNA vaccine design improves chances of inducing anti-tumour immunity

Scientists have devised a novel DNA vaccine approach through molecular design to improve the immune responses elicited against one of the most important cancer antigen targets. Study results were pub...

Research could lead to better vaccines and new antivirals

Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new regulator of the innate immune response—the immediate, natural immune response to foreign invaders. The s...

Cuba begins Phase 1 testing of HIV vaccine

Cuba has announced that it has begun testing a HIV vaccine that looks to reduce the ‘payload’ of the virus within the patients. The study will examine a small number of patients to determine the s...

Global Vaccine Contract Manufacturing Market Report 2017-2027

LONDON, February 27, 2017 /PRNewswire/ -- Leading Countries, Technologies and Companies The global vaccine contract manufacturing market is expected to grow at a CAGR of 8.9% from 2016-2021 an...

MabVax Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 17022017] Prices from USD $250

SummaryMabVax Therapeutics Inc MabVax Therapeutics, a subsidiary of MabVax Therapeutics Holdings Inc is a biopharmaceutical company that develops and commercializes anticancer immunotherapies from ant...

Events [0 Results]

None

Companies [109 Associated Companies listed on BioPortfolio]

IDT Biologika and CMC Biologics

IDT Biologika is an innovative life science company headquartered in Dessau, Germany with extensive expertise in research, development and manufacturing of vaccines, and in additi...

SynAffix

SynAffix is a protein engineering company located in Oss (the Netherlands), focused on the development of next-generation Antibody-Drug Conjugates (ADCs) for targeted cancer and other diseases. SynA...

TOMTEC

Tomtec has succeeded since 1967 by working with its clients to help solve their liquid handling needs. From 1967 to 1981, the Company had essentially one employee, Tom Astle. From 1967 to 1971, the Co...

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics is an Oxford, UK-based development stage biotechnology company with a particular focus on immune therapeutics in oncology. PsiOxus has developed a pate...

Neon Therapeutics

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allo...

VaxAlta Inc.

VaxAlta is a leading glycoconjugate vaccine research and development company based in Edmonton, Alberta. Founded in 2013, the company is focused on developing sugar-based, effecti...

IDT Biologika

IDT Biologika is an innovative, privately-held life science company with more than 94 years history and expertise in Research, Development and Manufacturing of biologics for the g...

ImmusanT, Inc.

ImmusanT is a privately held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented ...

Immunovaccine Inc.

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides control...

Clinical Trials [2847 Associated Clinical Trials listed on BioPortfolio]

Entolimod for Vaccine Augmentation (VA)

Our primary objective is to conduct a pilot study to evaluate the safety and adverse events of low dose Entolimod in normal, healthy, non-patient normals. This clinical trial in 40 normal ...

Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

The objective of this study is to evaluate the safety and efficacy of concurrent administration of influenza vaccine in patients receiving anti-PD1 immunotherapy (nivolumab or pembrolizuma...

The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells

Malignant tumor has become the leading cause of death in humans, and the number one killer in malignant tumor is the lung cancer. Intensifying environmental pollution comes with rising of ...

HPV IIS Reminder/Recall- New York State

The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centrali...

Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute

Title: Active surveillance for adverse events following immunization with the trivalent influenza vaccine (split virion and inactivated) produced at Butantan Institute. Rationale and back...

Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab

Patients with Crohn's disease (CD) and ulcerative colitis (UC) are often treated with medications that suppress the immune system. These patients are therefore at increased risk for develo...

Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study in Healthy Volunteers to Evaluate the Safety and Immunogenicity of AGS-v, a Universal Mosquito-Borne Disease Vaccine

Mosquito-borne diseases continue to cause significant morbidity and mortality worldwide despite on-going control efforts. In 2015, there were >200 million cases of malaria worldwide, causi...

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer

Background: Colorectal cancer is a common cancer in the U.S. It causes the second most cancer-related deaths. The drug avelumab and vaccine Ad-CEA together help the immune system fight ca...

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults

The purpose of this study is to evaluate the safety and immunogenicity of VEE vaccine, Live, Attenuated, dried TC-83, NDBR 102, Lot 4, Run 3, and collect data on the incidence of occupatio...

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

This randomized phase IV trial studies how well human papillomavirus (HPV) vaccine therapy works in interrupting progression in patients with high-grade vulvar or anal lesions. Vaccines ma...

Videos

None available.

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed)

Quick Search
Advertisement
 
review and buy Meningococcal Conjugates Vaccine market research data and corporate reports here

Channels Quicklinks